Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2024 ∙ Zhu, Y. Ouyang, X. Zhang, D. Wang, X. Wu, L. Yu, S. Tan, Y. Li, W. Li, C.
Alopecia areata following COVID-19 vaccine: a systematic review
Adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Yang, D. Tian, J. Shen, C. Li, Q.
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination
All age groups COVID-19 Safety
Rating:
Not applicable
2024 ∙ Lysak, K. Walulik, A. Blaszkiewicz, M. Gomulka, K.
ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination-A Systematic Review
Adults Older adults COVID-19 Safety Administration
Rating:
Critically low
2024 ∙ Arabzadeh Bahri, R. Esmaeilpur Abianeh, F. Peisepar, M. Hadi, R. Basti, F. A. Maleki, S. Radkhah, H.
Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review
Adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Cahuapaza-Gutierrez, N. L. Campos-Escalante, T. S.
Aplastic Anemia Following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series
Adults Older adults COVID-19 Safety
Rating:
Critically low
2024 ∙ Okpani, A. I. Adu, P. Paetkau, T. Lockhart, K. Yassi, A.
Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness
Healthcare workers COVID-19 Coverage
Rating:
Not applicable
2024 ∙ Uta, M. Craina, M. Marc, F. Enatescu, I.
Assessing the Impact of COVID-19 Vaccination on Preterm Birth: A Systematic Review with Meta-Analysis
Pregnant women COVID-19 Safety
Rating:
Low
2024 ∙ Sibanda, B. Haryanto, B.
Assessing the Impact of COVID-19 Vaccination Programs on the Reduction of COVID-19 Cases: A Systematic Literature Review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Vaman, R. S. Kumar, M. S. Jeyashree, K. Periasami, A. Abdulkader, R. S. Murhekar, M.
Association between COVID-19 Vaccination (ChAdOx1-S) and Thromboembolic, Thrombocytopenic, Hemorrhagic Events: A Systematic Review and Meta-analysis of Analytical Epidemiological Studies
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Rafati, A. Amanollahi, M. Pasebani, Y. Salimi, N. Kazemi, M. H. F. Jameie, M. Pasebani, M. Y. Sakhaei, D. Feizollahi, F. Kwon, C. S.
Association of new onset seizure and COVID-19 vaccines and long-term follow-up: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
Loading...